Table 2.
Adverse events, regardless of their relationship to the study drug.
| Adverse Event | All Grades | % | Grade 3–4 | % |
|---|---|---|---|---|
| Fatigue | 16 | 51.6% | ||
| LFT elevations | 15 | 48.4% | 2 | 6.5% |
| Nausea | 12 | 38.7% | ||
| Anorexia | 8 | 25.8% | ||
| Constipation | 6 | 19.4% | ||
| Diarrhea | 5 | 16.1% | ||
| Alopecia | 4 | 12.9% | ||
| Dehydration | 4 | 12.9% | 2 | 6.5% |
| Leukopenia | 3 | 9.7% | 2 | 6.5% |
| Neutropenia | 3 | 9.7% | 3 | 9.7% |
| Thrombocytopenia | 3 | 9.7% | 2 | 6.5% |
| Creatinine elevation | 3 | 9.7% | ||
| Headache | 3 | 9.7% | ||
| Bone pain | 3 | 9.7% | 2 | 6.5% |
| Anemia | 2 | 6.5% | 2 | 6.5% |